References
- Gharagozloo M, Majewski S, Foldvari M. Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction. Nanomedicine. 2015;11:1003–1018.
- Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al. Rituximab, b-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med. 2009;361:2143–2152.
- Herold KC, Gitelman SE, Ehlers MR, et al.; the AbATE Study Team. Teplizumab (anti-cd3 mab) treatment preserves c-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes. 2013;62:3766–3774.
- Steinman RM, Turley S, Mellman I, et al. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med. 2000;191:411–416.
- Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685–711.
- Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol. 2010;11:21–27.
- Sakaguchi S. Regulatory t cells: key controllers of immunologic self-tolerance. Cell. 2000;101:455–458.
- Rammensee HG, Kroschewski R, Frangoulis B. Clonal anergy induced in mature v beta 6+ t lymphocytes on immunizing mls-1b mice with mls-1a expressing cells. Nature. 1989;339:541–544.
- Fathman CG, Lineberry NB. Molecular mechanisms of cd4+ t-cell anergy. Nat Rev Immunol. 2007;7:599–609.
- Jenkins MK, Pardoll DM, Mizuguchi J, et al. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper t-lymphocyte clones. Proc Natl Acad Sci U S A. 1987;84:5409–5413.
- Jenkins MK, Chen CA, Jung G, et al. Inhibition of antigen-specific proliferation of type 1 murine t cell clones after stimulation with immobilized anti-cd3 monoclonal antibody. J Immunol. 1990;144:16–22.
- Schwartz RH. T cell anergy. Annu Rev Immunol. 2003;21:305–334.
- Safford M, Collins S, Lutz MA, et al. Egr-2 and egr-3 are negative regulators of t cell activation. Nat Immunol. 2005;6:472–480.
- Bachmaier K, Krawczyk C, Kozieradzki I, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor cbl-b. Nature. 2000;403:211–216.
- Anandasabapathy N, Ford GS, Bloom D, et al. Grail: an e3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic cd4+ t cells. Immunity. 2003;18:535–547.
- Getts DR, Turley DM, Smith CE, et al. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by pd-l1+ and il-10-producing splenic macrophages and maintained by t regulatory cells. J Immunol. 2011;187:2405–2417.
- Luo X, Pothoven KL, McCarthy D, et al. Ecdi-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc Natl Acad Sci U S A. 2008;105:14527–14532.
- Prasad S, Kohm AP, McMahon JS, et al. Pathogenesis of nod diabetes is initiated by reactivity to the insulin b chain 9-23 epitope and involves functional epitope spreading. J Autoimmun. 2012;39:347–353.
- Smarr CB, Hsu CL, Byrne AJ, et al. Antigen-fixed leukocytes tolerize th2 responses in mouse models of allergy. J Immunol. 2011;187:5090–5098.
- Lutterotti A, Yousef S, Sputtek A, et al. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci Transl Med. 2013;5:188ra75.
- Weyd H, Abeler-Dorner L, Linke B, et al. Annexin a1 on the surface of early apoptotic cells suppresses cd8+ t cell immunity. PLoS One. 2013;8:e62449.
- Linke B, Abeler-Dorner L, Jahndel V, et al. The tolerogenic function of annexins on apoptotic cells is mediated by the annexin core domain. JI. 2015;194:5233–5242.
- Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin i regulates neutrophil extravasation by interacting with the fpr. Mol Cell. 2000;5:831–840.
- Perretti M, Getting SJ, Solito E, et al. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol. 2001;158:1969–1973.
- Jain AA, Pasare C. Innate control of adaptive immunity: Beyond the three-signal paradigm. J Immunol. 2017;198:3791–3800.
- Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and disease. J Cell Biol. 2010;189:1059–1070.
- Savill J, Dransfield I, Gregory C, et al. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol. 2002;2:965–975.
- Kontos S, Grimm AJ, Hubbell JA. Engineering antigen-specific immunological tolerance. Curr Opin Immunol. 2015;35:80–88.
- Sharp FA, Ruane D, Claass B, et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the nalp3 inflammasome. Proc Natl Acad Sci U S A. 2009;106:870–875.
- Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13:397–411.
- Roberts RA, Eitas TK, Byrne JD, et al. Towards programming immune tolerance through geometric manipulation of phosphatidylserine. Biomaterials. 2015;72:1–10.
- Iborra S, Sancho D. Signalling versatility following self and non-self sensing by myeloid c-type lectin receptors. Immunobiology. 2015;220:175–184.
- Yamasaki S, Ishikawa E, Kohno M, et al. The quantity and duration of fcrgamma signals determine mast cell degranulation and survival. Blood. 2004;103:3093–3101.
- Hamerman JA, Ni M, Killebrew JR, et al. The expanding roles of itam adapters fcrgamma and dap12 in myeloid cells. Immunol Rev. 2009;232:42–58.
- Moss SE, Morgan RO. The annexins. Genome Biol. 2004;5:219.
- Blank U, Launay P, Benhamou M, et al. Inhibitory itams as novel regulators of immunity. Immunol Rev. 2009;232:59–71.
- Bode K, Bujupi F, Link C, et al. Dectin-1 Binding to Annexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2. Cell Reports. 2019;29(13):4435–4446.e9. doi:10.1016/j.celrep.2019.11.086.
- Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol. 2007;7:665–677.
- Kishimoto TK, Maldonado RA. Nanoparticles for the induction of antigen-specific immunological tolerance. Front Immunol. 2018;9:230.
- Whiting CC, Su LL, Lin JT, et al. Grail: a unique mediator of cd4 t-lymphocyte unresponsiveness. Febs j. 2011;278:47–58.